{"id":13854,"date":"2020-11-26T13:27:32","date_gmt":"2020-11-26T12:27:32","guid":{"rendered":"https:\/\/www.worldpolicyconference.com\/?p=13854"},"modified":"2020-11-26T13:27:32","modified_gmt":"2020-11-26T12:27:32","slug":"arthur-stril-2","status":"publish","type":"post","link":"https:\/\/www.worldpolicyconference.com\/fr\/arthur-stril-2\/","title":{"rendered":"Arthur Stril WPC \u2013 Health"},"content":{"rendered":"<p>Chief Business Officer and member of the Executive Committee of Cellectis. Prior to this position, he was Vice President, Corporate Development at Cellectis, responsible for program management, strategy and business development. Cellectis is a clinical-stage biopharmaceutical company developing gene-edited allogeneic CAR-T immunotherapies in oncology. Arthur began his career at the European Commission\u2019s Directorate-General for Competition, controlling global pharmaceutical mergers such as the Novartis\/GSK and Sanofi\/Boehringer Ingelheim asset swaps, Pfizer\u2019s acquisition of Hospira and Teva\u2019s acquisition of Actavis Generics. He later became Head of the Hospital Financing unit at the French Ministry of Health, where he led a team responsible for the \u20ac80bn hospital budget. Arthur graduated from the \u00c9cole Normale Sup\u00e9rieure, Paris and Cambridge University, and holds a diploma in Immunotherapy from the Universit\u00e9 Paris-Descartes. Arthur is also a member of the French Corps des Mines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chief Business Officer and member of the Executive Committee of Cellectis. Prior to this position, he was Vice President, Corporate Development at Cellectis, responsible for program management, strategy and business<\/p>\n","protected":false},"author":3,"featured_media":13855,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[38],"class_list":["post-13854","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-invited-guests","tag-38"],"_links":{"self":[{"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/posts\/13854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/comments?post=13854"}],"version-history":[{"count":0,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/posts\/13854\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/media\/13855"}],"wp:attachment":[{"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/media?parent=13854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/categories?post=13854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.worldpolicyconference.com\/fr\/wp-json\/wp\/v2\/tags?post=13854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}